INVO Bioscience is a medical devices business based in the US. INVO Bioscience shares (INVO) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.72 – the same closing value as a week prior. INVO Bioscience employs 25 staff and has a trailing 12-month revenue of around $5.8 million.
Offer ends 4/1/25. Customer must fund their Active invest account with at least $50 within 30 days of opening the account. Probability of customer receiving $2,000 is 0.028%. See full terms and conditions at https://www.sofi.com/greenintwoterms/.
Open an account.Provide your personal information and sign up.
Fund your account.Deposit funds into your account by linking your banking information or transfer funds from another trading account.
Search for the stock name – INVO.Search for the stock by name or ticker symbol.
Buy the stock. Place your order. It's that simple.
Buy INVO Bioscience stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
INVO Bioscience stock price (NASDAQ: INVO)
Use our graph to track the performance of INVO stocks over time.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
INVO Bioscience price performance over time
Historical closes compared with the close of $0.722 from 2024-12-23
1 week (2025-03-13)
N/A
1 month (2025-02-20)
N/A
3 months (2024-12-23)
0.722
6 months (2024-09-24)
4.12%
1 year (2024-03-22)
-36.11%
2 years (2023-03-23)
-94.51%
3 years (2022-03-24)
52.7
5 years (2020-03-24)
134.336
Is INVO Bioscience stock undervalued or overvalued?
Valuing INVO Bioscience stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of INVO Bioscience's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
INVO Bioscience's P/E ratio
INVO Bioscience's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 1x. In other words, INVO Bioscience shares trade at around 1x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
However, INVO Bioscience's P/E ratio is best considered in relation to those of others within the medical devices industry or those of similar companies.
We're not expecting INVO Bioscience to pay a dividend over the next 12 months.
You may also wish to consider:
Have INVO Bioscience's shares ever split?
INVO Bioscience's shares were
split on a 1:20 basis on 27 July 2023
. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your INVO Bioscience shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for INVO Bioscience shares which in turn could have impacted INVO Bioscience's share price.
INVO Bioscience share price volatility
Over the last 12 months, INVO Bioscience's shares have ranged in value from as little as $0.6311 up to $1.82. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while INVO Bioscience's is 1.436. This would suggest that INVO Bioscience's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
To put INVO Bioscience's beta into context you can compare it against those of similar companies.
INVO Bioscience, Inc. , together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida. .
Frequently asked questions
What percentage of INVO Bioscience is owned by insiders or institutions? Currently 0.63% of INVO Bioscience shares are held by insiders and 3.1% by institutions.How many people work for INVO Bioscience? Latest data suggests 25 work at INVO Bioscience.When does the fiscal year end for INVO Bioscience? INVO Bioscience's fiscal year ends in December.Where is INVO Bioscience based? INVO Bioscience's address is: 5582 Broadcast Court, Sarasota, FL, United States, 34240What is INVO Bioscience's ISIN number? INVO Bioscience's international securities identification number is: US44984F3029What is INVO Bioscience's CUSIP number? INVO Bioscience's Committee on Uniform Securities Identification Procedures number is: 44984F302
A deep dive into the highlights and limitations of Robinhood.
Advertiser disclosure
Finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which Finder receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. Finder compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
How likely would you be to recommend Finder to a friend or colleague?
0
1
2
3
4
5
6
7
8
9
10
Very UnlikelyExtremely Likely
Required
Thank you for your feedback.
Our goal is to create the best possible product, and your thoughts, ideas and suggestions play a major role in helping us identify opportunities to improve.
